FDA Inspection 1111733 — Horizon Therapeutics, PLC
The FDA completed an inspection of Horizon Therapeutics, PLC on November 1, 2019 in Lake Forest, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 1, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lake Forest, IL (United States)
Additional Details
Sponsor, Contract Research Organization